Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 8/20 | 0.70 |
| ▸ | XDH | P47989 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | PRKCA | P17252 | 2/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19004036 | 1.00 | HSP90AA1 (0.70) | HSP90AA1XDHCYP3A4KDM4EGLA | |
| SCHEMBL419313 | 0.97 | HSP90AA1 (0.71) | HSP90AA1XDHCYP3A4KDM4EGLA | |
| SCHEMBL29425944 | 0.96 | HSP90AA1 (0.70) | HSP90AA1XDHCYP3A4KDM4EGLA | |
| SCHEMBL29426068 | 0.94 | HSP90AA1 (0.70) | HSP90AA1XDHCYP3A4KDM4EGLA | |
| SCHEMBL23685612 | 0.93 | HSP90AA1 (0.65) | HSP90AA1XDHCYP3A4KDM4EGLA | |
| SCHEMBL29426089 | 0.92 | HSP90AA1 (0.73) | HSP90AA1XDHCYP3A4KDM4EGLA | |
| SCHEMBL29425878 | 0.90 | HSP90AA1 (0.80) | HSP90AA1XDHCYP3A4KDM4EGLA | |
| SCHEMBL21238175 | 0.90 | HSP90AA1 (0.55) | HSP90AA1XDHCYP3A4KDM4EGLA | |
| SCHEMBL419954 | 0.89 | HSP90AA1 (0.60) | HSP90AA1XDHCYP3A4KDM4EGLA | |
| SCHEMBL422039 | 0.89 | HSP90AA1 (0.71) | HSP90AA1XDHCYP3A4KDM4EGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| WO-2023035479-A1 | TRADITIONAL CHINESE MEDICINE COMPOSITE, TRADITIONAL CHINESE MEDICINE EFFECTIVE COMPONENT COMPOSITION, COMPOUND AND APPLICATIONS THEREOF | 北京中医药大学 | 2023-03-16 | — | — | WO | claimed |
| US-12194063-B2 | Traditional Chinese medicine mixture and traditional Chinese medicine effective ingredient compound with function of promoting directional differentiation of stem cells into cardiomyocytes, and applications thereof | BEIJING UNIVERSITY OF CHINESE MEDICINE (CN) | 2025-01-14 | — | — | US | disclosed |
| US-12194063-B2 | Traditional Chinese medicine mixture and traditional Chinese medicine effective ingredient compound with function of promoting directional differentiation of stem cells into cardiomyocytes, and applications thereof | BEIJING UNIVERSITY OF CHINESE MEDICINE (CN) | 2025-01-14 | — | — | US | disclosed |
| US-20240180973-A1 | TRADITIONAL CHINESE MEDICINE MIXTURE AND TRADITIONAL CHINESE MEDICINE EFFECTIVE INGREDIENT COMPOUND WITH FUNCTION OF PROMOTING DIRECTIONAL DIFFERENTIATION OF STEM CELLS INTO CARDIOMYOCYTES, AND APPLICATIONS THEREOF | BEIJING UNIVERSITY OF CHINESE MEDICINE (CN) | 2024-06-06 | — | — | US | disclosed |
| US-20240180973-A1 | TRADITIONAL CHINESE MEDICINE MIXTURE AND TRADITIONAL CHINESE MEDICINE EFFECTIVE INGREDIENT COMPOUND WITH FUNCTION OF PROMOTING DIRECTIONAL DIFFERENTIATION OF STEM CELLS INTO CARDIOMYOCYTES, AND APPLICATIONS THEREOF | BEIJING UNIVERSITY OF CHINESE MEDICINE (CN) | 2024-06-06 | — | — | US | disclosed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023035479-A1 | TRADITIONAL CHINESE MEDICINE COMPOSITE, TRADITIONAL CHINESE MEDICINE EFFECTIVE COMPONENT COMPOSITION, COMPOUND AND APPLICATIONS THEREOF | 北京中医药大学 | 2023-03-16 | — | — | WO | disclosed |
| WO-2023035479-A1 | TRADITIONAL CHINESE MEDICINE COMPOSITE, TRADITIONAL CHINESE MEDICINE EFFECTIVE COMPONENT COMPOSITION, COMPOUND AND APPLICATIONS THEREOF | 北京中医药大学 | 2023-03-16 | — | — | WO | disclosed |
| CN-113662985-B | Traditional Chinese medicine composition with effect of promoting directional differentiation of stem cells into myocardial cells, traditional Chinese medicine effective component composition and application thereof | 北京中医药大学 | 2022-06-24 | — | — | CN | disclosed |
| CN-113662985-B | Traditional Chinese medicine composition with effect of promoting directional differentiation of stem cells into myocardial cells, traditional Chinese medicine effective component composition and application thereof | 北京中医药大学 | 2022-06-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12194063-B2 | Traditional Chinese medicine mixture and traditional Chinese medicine effective ingredient compound with function of promoting directional differentiation of stem cells into cardiomyocytes, and applications thereof | ATP6V1B2, VIP, CHRNA4 | HSP90AA1 3924/4885XDH 3823/4885CYP3A4 2171/4885 |
| US-20240180973-A1 | TRADITIONAL CHINESE MEDICINE MIXTURE AND TRADITIONAL CHINESE MEDICINE EFFECTIVE INGREDIENT COMPOUND WITH FUNCTION OF PROMOTING DIRECTIONAL DIFFERENTIATION OF STEM CELLS INTO CARDIOMYOCYTES, AND APPLICATIONS THEREOF | ATP6V1B2, VIP, CHRNA4 | HSP90AA1 3924/4885XDH 3823/4885CYP3A4 2171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.